BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29368435)

  • 1. p62 as a therapeutic target for inhibition of autophagy in prostate cancer.
    Wang L; Kim D; Wise JTF; Shi X; Zhang Z; DiPaola RS
    Prostate; 2018 Apr; 78(5):390-400. PubMed ID: 29368435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis.
    Son YO; Pratheeshkumar P; Roy RV; Hitron JA; Wang L; Zhang Z; Shi X
    J Biol Chem; 2014 Oct; 289(41):28660-75. PubMed ID: 25157103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of rapamycin and garlic-derived S-allylmercaptocysteine induces colon cancer cell apoptosis and suppresses tumor growth in xenograft nude mice through autophagy/p62/Nrf2 pathway.
    Li S; Yang G; Zhu X; Cheng L; Sun Y; Zhao Z
    Oncol Rep; 2017 Sep; 38(3):1637-1644. PubMed ID: 28737825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of ROS, Nrf2, and autophagy in cadmium-carcinogenesis and its prevention by sulforaphane.
    Wang Y; Mandal AK; Son YO; Pratheeshkumar P; Wise JTF; Wang L; Zhang Z; Shi X; Chen Z
    Toxicol Appl Pharmacol; 2018 Aug; 353():23-30. PubMed ID: 29885333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced Carcinogenesis.
    Son YO; Pratheeshkumar P; Roy RV; Hitron JA; Wang L; Divya SP; Xu M; Luo J; Chen G; Zhang Z; Shi X
    J Biol Chem; 2015 Nov; 290(45):27090-27100. PubMed ID: 26385919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p62 promotes proliferation, apoptosis‑resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis.
    Jiang G; Liang X; Huang Y; Lan Z; Zhang Z; Su Z; Fang Z; Lai Y; Yao W; Liu T; Hu L; Wang F; Huang H; Liu L; Jiang X
    Oncol Rep; 2020 May; 43(5):1547-1557. PubMed ID: 32323805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chalcone flavokawain B induces autophagic-cell death via reactive oxygen species-mediated signaling pathways in human gastric carcinoma and suppresses tumor growth in nude mice.
    Chang CT; Hseu YC; Thiyagarajan V; Lin KY; Way TD; Korivi M; Liao JW; Yang HL
    Arch Toxicol; 2017 Oct; 91(10):3341-3364. PubMed ID: 28374157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin.
    Donohue E; Balgi AD; Komatsu M; Roberge M
    PLoS One; 2014; 9(12):e114964. PubMed ID: 25494214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
    Singh K; Sharma A; Mir MC; Drazba JA; Heston WD; Magi-Galluzzi C; Hansel D; Rubin BP; Klein EA; Almasan A
    Mol Cancer; 2014 Mar; 13():70. PubMed ID: 24655592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling.
    Rubio N; Verrax J; Dewaele M; Verfaillie T; Johansen T; Piette J; Agostinis P
    Free Radic Biol Med; 2014 Feb; 67():292-303. PubMed ID: 24269898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.
    Shin D; Kim EH; Lee J; Roh JL
    Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dual inhibition of apoptosis and autophagy in prostate cancer.
    Saleem A; Dvorzhinski D; Santanam U; Mathew R; Bray K; Stein M; White E; DiPaola RS
    Prostate; 2012 Sep; 72(12):1374-81. PubMed ID: 22241682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PA-MSHA inhibits the growth of doxorubicin-resistant MCF-7/ADR human breast cancer cells by downregulating Nrf2/p62.
    Wei Y; Liu D; Jin X; Gao P; Wang Q; Zhang J; Zhang N
    Cancer Med; 2016 Dec; 5(12):3520-3531. PubMed ID: 27758045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6.
    Jiang X; Huang Y; Liang X; Jiang F; He Y; Li T; Xu G; Zhao H; Yang W; Jiang G; Su Z; Jiang L; Liu L
    Prostate; 2018 May; 78(6):426-434. PubMed ID: 29383752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway.
    You D; Kim Y; Jang MJ; Lee C; Jeong IG; Cho YM; Hwang JJ; Hong JH; Ahn H; Kim CS
    PLoS One; 2015; 10(9):e0137589. PubMed ID: 26352139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancratistatin induces apoptosis and autophagy in metastatic prostate cancer cells.
    Griffin C; McNulty J; Pandey S
    Int J Oncol; 2011 Jun; 38(6):1549-56. PubMed ID: 21424119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1.
    Zhang H; Ramakrishnan SK; Triner D; Centofanti B; Maitra D; Győrffy B; Sebolt-Leopold JS; Dame MK; Varani J; Brenner DE; Fearon ER; Omary MB; Shah YM
    Sci Signal; 2015 Oct; 8(397):ra98. PubMed ID: 26443705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pepper's natural ingredient capsaicin induces autophagy blockage in prostate cancer cells.
    Ramos-Torres Á; Bort A; Morell C; Rodríguez-Henche N; Díaz-Laviada I
    Oncotarget; 2016 Jan; 7(2):1569-83. PubMed ID: 26625315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
    Ma K; Zhang C; Huang MY; Li WY; Hu GQ
    Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib-induced defective autophagy promotes cell death by necroptosis.
    Kharaziha P; Chioureas D; Baltatzis G; Fonseca P; Rodriguez P; Gogvadze V; Lennartsson L; Björklund AC; Zhivotovsky B; Grandér D; Egevad L; Nilsson S; Panaretakis T
    Oncotarget; 2015 Nov; 6(35):37066-82. PubMed ID: 26416459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.